Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,914 across all filing types
Latest filing 2023-05-30 Annual Report
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
as per annexure enclosed
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Apollo Hospitals regarding the outcome of a Board Meeting held on May 30, 2023. It includes audited standalone and consolidated financial results for the fiscal year ended March 31, 2023, along with audit reports. It also discusses dividend recommendations, the scheduling of the Annual General Meeting (AGM), fixation of record dates, and re-appointment proposals for Independent Directors. The document references compliance with SEBI Listing Regulations and includes disclosures related to director re-appointments. The length of the document (15,000 characters) and the inclusion of substantive financial data and audit reports indicate this is not merely an announcement of a report but contains the actual financial results and related information. Therefore, this document is best classified as an Annual Report (10-K equivalent) or a comprehensive financial results announcement. However, since it includes audited financial results for the full fiscal year and audit reports, it aligns most closely with the Annual Report (10-K) category rather than a quarterly or interim report. It is not a simple earnings release or a regulatory filing. Hence, the appropriate classification is Annual Report (10-K).
2023-05-30 English
Date of payment of dividend
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Apollo Hospitals regarding the outcome of a Board Meeting held on May 30, 2023. It includes audited standalone and consolidated financial results for the fiscal year ended March 31, 2023, along with audit reports. It also discusses dividend recommendations, the scheduling of the Annual General Meeting (AGM), fixation of record dates, and re-appointment proposals for Independent Directors. The document references compliance with SEBI Listing Regulations and includes disclosures related to director re-appointments. The length of the document (15,000 characters) and the inclusion of substantive financial results and audit reports indicate this is not merely an announcement of a report but contains the actual financial data and related corporate governance information. Therefore, this document is best classified as an Annual Report (10-K equivalent) or a comprehensive financial results announcement with audit reports. However, since it includes audited financial results for the full fiscal year and audit reports, it aligns most closely with the Annual Report (10-K) category rather than a quarterly or interim report or a simple earnings release. It also contains management and board information but the primary focus is on the audited financial results and audit reports for the full year, which is characteristic of an Annual Report filing.
2023-05-30 English
Appointment
Regulatory Filings
2023-05-30 English
Appointment
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Apollo Hospitals regarding the outcome of a Board Meeting held on May 30, 2023. It includes audited standalone and consolidated financial results for the fiscal year ended March 31, 2023, along with audit reports. It also discusses dividend recommendations, the scheduling of the Annual General Meeting (AGM), fixation of record dates, and re-appointment proposals for Independent Directors. The document references compliance with SEBI Listing Regulations and includes disclosures required by SEBI circulars. The content is comprehensive, covering financial results, governance matters, and meeting details, indicating it is a formal regulatory filing announcing the board meeting outcomes and financial results rather than the full annual report itself. The document length is 15,000 characters, which is substantial but typical for a detailed board meeting outcome announcement. Since it includes audited financial results and audit reports but is primarily an announcement of these outcomes and related corporate actions, it fits best under Regulatory Filings (RNS) rather than the full Annual Report (10-K) or Audit Report (AR).
2023-05-30 English
Appointment
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Apollo Hospitals regarding the outcome of a Board Meeting held on May 30, 2023. It includes audited standalone and consolidated financial results for the fiscal year ended March 31, 2023, along with audit reports. It also discusses dividend recommendations, the scheduling of the Annual General Meeting (AGM), fixation of record dates, and re-appointment proposals for Independent Directors. The document references compliance with SEBI Listing Regulations and includes disclosures related to director re-appointments. The content is comprehensive, covering financial results, governance matters, and shareholder meeting details, indicating it is a formal regulatory announcement of financial results and board decisions rather than the full annual report itself. The presence of audited financial results and audit reports suggests it is more than a simple earnings release but does not contain the full annual report narrative or extensive financial statements. Given the detailed financial results and audit reports, and the regulatory context, this document fits best as a Capital/Financing Update (CAP) or possibly an Earnings Release (ER). However, since it includes audited annual financial results and audit reports, it is more aligned with a Capital/Financing Update (CAP) which often includes such comprehensive financial disclosures and board decisions. It is not a full Annual Report (10-K) as it lacks the full narrative and detailed disclosures typical of such reports. It is not a Regulatory Filing (RNS) because it contains substantive financial data and audit reports, not just a certification or announcement. Therefore, the best classification is Capital/Financing Update (CAP).
2023-05-30 English
Record Date
Regulatory Filings Classification · 90% confidence The document is an official communication addressed to stock exchanges regarding the outcome of a Board Meeting held on May 30, 2023. It includes audited standalone and consolidated financial results for the fiscal year ended March 31, 2023, along with audit reports. It also discusses dividend recommendations, the scheduling of the Annual General Meeting (AGM), fixation of record date, and re-appointment proposals for Independent Directors. The document references compliance with SEBI Listing Regulations and includes detailed disclosures about director re-appointments. The content is comprehensive, covering financial results, audit reports, dividend, AGM details, and board management changes. This combination of audited financial results and audit reports for the full fiscal year indicates it is the Annual Report or equivalent financial results announcement. However, since the document is primarily an announcement of the Board Meeting outcomes including financial results and audit reports, and not the full Annual Report itself, it fits best as a Regulatory Filing (RNS) under SEBI regulations. The document is lengthy (15,000 characters) and contains substantive financial data and audit opinions, but it is structured as an official intimation rather than the full Annual Report document. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.